Despite the trial failure, Sarepta will still seek full approval of AMONDYS 45 and VYONDYS 53 in DMD from the FDA.
At the European Society for Medical Oncology (ESMO) 2025 event, held in Berlin, Germany, between 17-21 October, Celcuity ...
Centessa is advancing ORX750 to pivotal trials based on the Phase IIa data. Image credit: SOPA Images /LightRocket via Getty Images Centessa Pharmaceuticals executives will be breathing a sigh of ...
The trial aims to provide safety and efficacy data for submissions to regulatory agencies in the US and Europe. Credit: rathshiki / Shutterstock.com. Vir Biotechnology has concluded subject enrolment ...
Novo Nordisk said that the data suggests that the benefits of Wegovy go further than just weight loss in the patient population. Image credit: PJ McDonnell / Shutterstock.com. Novo Nordisk’s oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback